Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 6, 2021
Treatment of vulvar and vaginal dysplasia: plasma energy ablation versus carbon dioxide laser ablationAnna Beavis, Omar Najjar, Tricia Murdock, et al.
Gynecologic Oncology|October 20, 2018
A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancerEdward J Tanner, Olga T Filippova, Ginger J Gardner, et al.
American Journal of Obstetrics and Gynecology|December 31, 2016
Patient, surgeon, and hospital disparities associated with benign hysterectomy approach and perioperative complicationsAmbar Mehta, Tim Xu, Susan Hutfless, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 2019
The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial CancerEdward J Tanner, Laureen Ojalvo, Rebecca Lynn Stone, et al.
Cancer Research|July 2, 2020
FTO-Dependent N 6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP SignalingHao Huang, Yinu Wang, Manoj Kandpal, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 18, 2019
Laparoscopic surgical access in morbidly obese women undergoing endometrial cancer surgery: Repurposing the left upper quadrant approachAaron Varghese, Elizabeth Peijnenburg, Rebecca L Stone, et al.
Gynecologic Oncology|October 11, 2011
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancerEdward J Tanner, Destin R Black, Oliver Zivanovic, et al.
Gynecologic Oncology|September 29, 2012
Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancerEdward J Tanner, Kara C Long, Jill B Feffer, et al.
Gynecologic Oncology|March 1, 2011
A microRNA survival signature (MiSS) for advanced ovarian cancerKarin K Shih, Li-Xuan Qin, Edward J Tanner, et al.
Gynecologic Oncology|December 17, 2013
The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group studyAmanda Nickles Fader, James Java, Thomas C Krivak, et al.
Pageof 7